Pharmaceutical Investing Novartis Advanced Accelerator Applications Receives FDA Approval for Lutathera
Pharmaceutical Investing Novartis completes tender offer for Advanced Accelerator Applications S.A. and commencement of subsequent offering period
Advanced Accelerator Applications Announces Pricing of $150 Million Public Offering of American Depositary Shares
ITEL signs agreement with Advanced Accelerator Applications to commercialize F-18 radiopharmaceuticals in Southern Italy
Significant intercepts of gold and copper show Golden Eye emerging as a highly promising new resource prospect
Alvopetro Announces an Operational Update, Q1 2025 Financial Results and Details for our Upcoming AGM
Grande Portage Stakes Added Claims to Accommodate Potential Surface Facilities at the New Amalga Gold Project